What is Stryker's ortho tech — net sales?

Stryker (SYK) reported ortho tech — net sales of $646M in Q1 2026.

What does ortho tech — net sales mean?

This metric represents the total revenue generated from the sale of orthopedic technology products, including reconstructive implants for hips and knees as well as related surgical instruments. It serves as a primary indicator of the company's market penetration and demand within the musculoskeletal and joint replacement sector. Tracking this revenue stream provides insight into the performance of the company's core medical device portfolio against broader orthopedic market trends.

Stryker SYK Ortho Tech — Net Sales

Other product segments

Trauma and Extremities

$1.04B+9.5%

Instruments

$920M+9.8%

Medical

$902M-4.6%

Endoscopy

$868M+0.1%

Knees

$670M+4.9%

Vascular

$517M+27.3%

Hips

$460M+3.8%

Spine

$8M-95.7%

Similar metrics at other companies

CNMDOrthopedic Surgery — Net Sales

$147.66M+6.8%

XRAYOrthodontics — Net Sales

$45M-23.7%

XRAYOrthodontic and Implant Solutions — Net Sales

$199M-8.3%

GMEDMusculoskeletal Solutions — Net Sales

$732.98M+27.3%

BVSRestorative Therapies — Total Net Sales

$20.64M+4.6%

MDXGSurgical — Net Sales

$36.37M+13.2%

Other financials

Income statement

See full

Revenue$6.0B+2.6%

Gross profit$3.8B+1.8%

Operating income$936.0M+11.8%

Net income$745.0M+13.9%

EPS (diluted)$1.93+14.2%

Balance sheet

See full

Cash & equivalents$2.9B+24.1%

Total debt$14.4B-15.1%

Total assets$46.3B+0.6%

Cash flow

See full

Operating cash flow$581.0M+132%

CapEx$166.0M+35.0%

Free cash flow$415.0M+227%

Valuation

See full

Market cap$121.18B-15.6%

Enterprise value$132.69B-16.1%

P/E36.3×-13.9×

P/S4.8×-1.4×

Profitability

See full

Gross margin63.8%-0.1pp

Operating margin19.7%+4.4pp

Net margin13.2%+0.9pp

FCF margin18.1%+2.7pp

Returns & leverage

See full

Return on equity32.8%—

Debt / equity0.8×—

Current ratio2.1×+0.5×

Where this comes from

Reported directly by Stryker in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Stryker’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stryker's ortho tech — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Stryker's ortho tech — net sales?: Stryker (SYK) reported ortho tech — net sales of $646M in Q1 2026.
What does ortho tech — net sales mean?: This metric represents the total revenue generated from the sale of orthopedic technology products, including reconstructive implants for hips and knees as well as related surgical instruments. It serves as a primary indicator of the company's market penetration and demand within the musculoskeletal and joint replacement sector. Tracking this revenue stream provides insight into the performance of the company's core medical device portfolio against broader orthopedic market trends.